LionBird is a venture capital firm based in Tel Aviv, Israel, investing in pre-scale digital health and healthcare technology companies. The firm provides capital and assistance to mission-driven teams building technology to fix healthcare.
47% of their portfolio is in Healthcare. Average disclosed round size is $19.7M (across 48 rounds with reported amounts).
Portfolio
31
Fund Size
$85M
Top Stage
Seed
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
51 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Rhino Federated Computing | Series A | $15M | May 2025 |
 Rhino | Series A | $15M | May 2025 |
 PhaseV | Series A | $50M | May 2025 |
 Phantom Neuro | Series A | $19M | Apr 2025 |
| Phantom Neuro | Series A | $19M | Jan 2025 |
| Rhino Federated Computing | Unknown | $15M | Jan 2025 |
 Jimini Health | Pre-Seed | $8M | Nov 2024 |
 Patient Partner | Seed | $7M | Sep 2024 |
 Heyday Health | Series A | $12.5M | Jun 2024 |
| Jimini Health | Pre-Seed | $8M | Jan 2024 |
 Black Ore | Series C | $60M | Nov 2023 |
| PhaseV | Seed | $9M | Oct 2023 |
 Mana Bio | Seed | $19.5M | Oct 2023 |
 Chiefy | Seed | $4.2M | Apr 2023 |
 Nest Genomics | Seed | $8.5M | Jan 2023 |
| Phantom Neuro | Seed | $6M | Oct 2022 |
 Theranica | Series C | $45M | Aug 2022 |
 FundGuard | Series B | $40M | Apr 2022 |
| MMaverick Medical | Seed | $5M | Mar 2022 |
 Maverick Medical AI | Seed | $5M | Mar 2022 |
 Protenus | Series D | $21M | Jun 2021 |
 C2i Genomics | Series C | $100M | Apr 2021 |
| RRhino Health | Seed | $5M | Feb 2021 |
| C2i Genomics | Seed | $100M | Jan 2021 |
 reMesh | Series A | $25M | Mar 2020 |
Page 1 of 3
Top Co-Investors
Techstars7 shared
Gaingels7 shared
Kaiser Permanente Ventures6 shared
Blumberg Capital5 shared
Zetta Venture Partners5 shared
BoxGroup5 shared
General Catalyst4 shared
Team84 shared
F-Prime Capital4 shared
Lightbank4 shared
aMoon3 shared
Lightspeed Venture Partners3 shared
NFX3 shared
Arkitekt Ventures3 shared
private angel investors3 shared
Breakout Ventures3 shared
Time BioVentures3 shared
Draper Associates3 shared
Casdin Capital3 shared
Arthur Ventures3 shared
Last updated: 20 October 2026